Snowdon, a New Brunswick, N.J., drug developer, received a $500,000 grant from the New Jersey Commission on Science & Technology. The grant matches $500,000 the company raised in March from the Foundation Venture Capital Group.
Snowdon is developing new treatments against cancer, pain and infectious parasitic diseases.
Tags: biotechnology, co:Snowdon, grant, inv:Foundation-Venture-Capital-Group, inv:New-Jersey-Commission-on-Science-&-Technology
Trackback URL
